Due to the impact of COVID-19 and associated travel and physical distancing restrictions the 7th Thomas Ashworth Symposium will be delayed until 21-22nd October 2021. We plan to hold TAS2021 in Sydney at the UTS Aerial Function Centre.
For 2020 we will be hosting a joint TAS-AGTG Live afternoon symposium on Thursday 15th October 2020.
Please click on the link to take you to the TAS-AGTA Live page.
For 2020 we will be hosting a joint TAS-AGTG Live afternoon symposium on Thursday 15th October 2020.
Please click on the link to take you to the TAS-AGTA Live page.
7th Thomas Ashworth Symposium (TAS2021)
Date: 21-22 October 2021
Registration opens: TBA
Earlybird registration closes: 11th September 2021
Final registration closes: 14th October 2021
Date: 21-22 October 2021
Registration opens: TBA
Earlybird registration closes: 11th September 2021
Final registration closes: 14th October 2021
Showcasing the best of international and national liquid biopsy research
The Thomas Ashworth CTC & Liquid Biopsy Symposium is devoted to advancing the clinical application of liquid biopsy to enhance precision oncology and improve patient outcome as well as provide critical insights into the metastatic process, minimal residual disease and cancer biology.
An exciting line up of international leaders in the field, supported by national speakers from across Australia will be showcasing their liquid biopsy research.
Confirmed 2021 Keynote Speakers
• Professor Razelle Kurzrock (MD, PhD). University of California, San Diego, USA
• Professor Maarten IJzerman (PhD). University of Melbourne, Australia
Topics to be explored include circulating tumour cells, ctDNA, exosomes, methlated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring, recurrence and drug resistance monitoring.
Who should attend?
For more information please email k.spring@westernsydney.edu.au
The Thomas Ashworth CTC & Liquid Biopsy Symposium is devoted to advancing the clinical application of liquid biopsy to enhance precision oncology and improve patient outcome as well as provide critical insights into the metastatic process, minimal residual disease and cancer biology.
An exciting line up of international leaders in the field, supported by national speakers from across Australia will be showcasing their liquid biopsy research.
Confirmed 2021 Keynote Speakers
• Professor Razelle Kurzrock (MD, PhD). University of California, San Diego, USA
• Professor Maarten IJzerman (PhD). University of Melbourne, Australia
Topics to be explored include circulating tumour cells, ctDNA, exosomes, methlated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring, recurrence and drug resistance monitoring.
Who should attend?
- Translational/clinical researchers
- Medical oncologists
- Pathologists
- Clinical trainees, PhD and other students
- Pharmaceutical and diagnostic sector
For more information please email k.spring@westernsydney.edu.au
Sponsors
Host Institutions
|
|
|
|